13.01.2013 Views

omation mbers - Society for Laboratory Automation and Screening

omation mbers - Society for Laboratory Automation and Screening

omation mbers - Society for Laboratory Automation and Screening

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TP039<br />

Patrick Goertz<br />

University of Texas at Austin<br />

Institute <strong>for</strong> Cellular <strong>and</strong> Molecular Biology<br />

1 University Station A4800<br />

Austin, Texas 78712-0159<br />

goertz.p@mail.utexas.edu<br />

Automated Selection of Aminoglycoside Antibiotic Aptamers<br />

165<br />

Co-Author(s)<br />

J. Colin Cox<br />

Andrew D. Ellington<br />

The in vitro selection of aptamers that bind to low molecular weight targets is commonly a tedious, timeconsuming<br />

project. Aptamers are short (~80 nt) segments of nucleic acid that have been shown to mimic many<br />

properties of antibodies <strong>and</strong> which bind with high specificity <strong>and</strong> affinity to molecular targets. The process of<br />

selecting aptamers includes several rounds of combining the target with a r<strong>and</strong>omized pool of nucleic acid,<br />

washing away the non-binding species, <strong>and</strong> amplifying the bound me<strong>mbers</strong>. Subsequent iterations of this process<br />

narrow down the nucleic acid pool to the strongest binding species. We have exp<strong>and</strong>ed current automated<br />

selection protocols to include aptamer selections against small molecules including the aminoglycoside antibiotic<br />

neomycin. This modified procedure decreases both the frequency of manual h<strong>and</strong>ling of the selection reagents<br />

<strong>and</strong> the time required to per<strong>for</strong>m the experiment generating aptamers against the chosen target at a much greater<br />

rate. The method is suitable <strong>for</strong> integration with high throughput technologies, greatly exp<strong>and</strong>ing the possibility<br />

of discovering useful aptamers against other low weight targets. Such targets could include those with important<br />

diagnostic value such as neurotransmitters.<br />

TP040<br />

Norbert Gottschlich<br />

Greiner Bio-One, Inc.<br />

Maybachstrasse 2<br />

Frickenhausen72636 Germany<br />

norbert.gottschlich@gbo.com<br />

Mass Production of Plastic Chips <strong>for</strong> Microfluidic Applications<br />

Co-Author(s)<br />

A. Gerlach, G. Knebel,<br />

W. Hoffmann, A. E. Guber,<br />

Forschungszentrum Karlsruhe,<br />

Institut für Mikrostrukturtechnik<br />

Germany<br />

Commonly, microfluidic chips <strong>for</strong> medical diagnostics or life sciences are made from glass or silicon. Over the last<br />

years, however, polymers have gained great interest as substrates since they promise lower manufacturing costs.<br />

In addition, polymers are available with a wide range of excellent physical <strong>and</strong> chemical properties. For a low-cost<br />

production of microfluidic systems as single-use products, adequate manufacturing techniques are required. We<br />

have produced several microfluidic systems from various plastic materials, mainly <strong>for</strong> Capillary Electrophoresis<br />

(CE). The microchannel systems were either molded into the plastic substrate by vacuum hot embossing or<br />

produced by optimized injection molding. Routinely, mechanical micromachining was used to create the required<br />

metal molding tools. Extremely precise mold inserts could be generated by galvanic/lithographic processes.<br />

The CE chips have been used to separate both DNA fragments <strong>and</strong> mixtures of inorganic ions. Detection was<br />

carried out either by laser induced fluorescence (LIF) or by electrical methods. In the latter case, contact-free<br />

conductivity detection with electrodes located outside of the CE system was used. Microstructures have also been<br />

incorporated in a larger <strong>for</strong>mat that meets the st<strong>and</strong>ardized microplate footprint commonly used in high throughput<br />

screening (HTS). Microfluidic plates with 96 or 384 identical microstructures <strong>for</strong> applications in HTS, clinical<br />

diagnostics, <strong>and</strong> gene analysis have been manufactured as well.<br />

POSTER ABSTRACTS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!